Match!
Anne C. Spaulding
Emory University
105Publications
26H-index
2,237Citations
Publications 105
Newest
#1Sheena Gardner (MSU: Mississippi State University)H-Index: 3
#2Katherine S. Elkington (Columbia University)H-Index: 20
Last.Connie Baird-Thomas (MSU: Mississippi State University)H-Index: 5
view all 9 authors...
Background While involvement in the legal system offers an opportunity to educate, screen, and treat high-risk youth, research shows that staff attitudes toward these practices can serve as barriers to implementation. The current study investigates the degree to which JJ staff endorse HIV prevention, testing, and treatment linkage practices with youth under community supervision and examines differences between individuals who supervise youth (e.g., juvenile probation officer) and those working ...
#1Anne C. Spaulding (Emory University)H-Index: 26
#2Junyu Chen (Emory University)H-Index: 1
Last.Karla Thornton (UNM: University of New Mexico)H-Index: 9
view all 7 authors...
#1Turgay Ayer (Georgia Institute of Technology)H-Index: 15
#2Can Zhang (Duke University)H-Index: 1
Last.Jagpreet Chhatwal (Harvard University)H-Index: 21
view all 5 authors...
Hepatitis C virus (HCV) prevalence in prison systems is about 10 times higher than in the community. As such, prison systems offer a unique opportunity to control the HCV epidemic. New HCV-treatmen...
#1Anne C. Spaulding (Emory University)H-Index: 26
#2Haley E. Kehus (Emory University)
Last.William J. Sabol (GSU: Georgia State University)
view all 3 authors...
#1Anne C. Spaulding (Emory University)H-Index: 26
#2Camilla S. Graham (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 16
Last.Stacey Trooskin (Philadelphia Fight)H-Index: 8
view all 12 authors...
#1Anne C. Spaulding (Morehouse School of Medicine)H-Index: 26
#2Jagpreet Chhatwal (Harvard University)H-Index: 21
Last.William von OehsenH-Index: 1
view all 6 authors...
The cost of treating all incarcerated people who have hepatitis C with direct-acting antiviral agents (DAAs) greatly stresses correctional facility budgets. Complex federal laws bar pharmaceutical companies from simply discounting expensive medications to prices that facilities can afford. This article discusses means by which correctional facilities may qualify under federal law as “safety-net providers” to allow sale of DAAs at a price <10% of the average manufacturer price (AMP). No new laws ...
#1Jennifer E. Becan (TCU: Texas Christian University)H-Index: 8
#2John P. Bartkowski (UTSA: University of Texas at San Antonio)H-Index: 30
Last.Matthew L. Hiller (TU: Temple University)H-Index: 24
view all 16 authors...
This paper describes the means by which a United States National Institute on Drug Abuse (NIDA)-funded cooperative, Juvenile Justice-Translational Research on Interventions for Adolescents in the Legal System (JJ-TRIALS), utilized an established implementation science framework in conducting a multi-site, multi-research center implementation intervention initiative. The initiative aimed to bolster the ability of juvenile justice agencies to address unmet client needs related to substance use whi...
12345678910